There are 1 gynecologic cancer surger from 1 suppliers on EC21.com
Related Searches : aluminum composite panel , acp , aluminium composite panel , panel , alucobond , pvdf acp
Supplier Info.
Report Item
Your report on Product(s) will be sent to EC21 Administrators once submitted.
Then, Administrators will investigate and then take appropriate actions.
Contact Supplier
This test detects 346 genes, including HRR pathway genes. The content involves targeted therapy, immunotherapy, chemotherapy and hereditary risk assessment, and provides comprehensive medication reference for prostate cancer patients. Features of Individualized Medication Guidance for Prostate Cancer Diagnosis Targeted therapy-Including SNV, InDel, CNV and gene rearrangement, comprehensively guide targeted drug use. Immunotherapy-Detect TMB and MSI indicators, as well as positive and negative immune-related genes, provide information to guide immunosuppressive therapy. Chemotherapy- Detect chemotherapeutic drug loci associated with prostate cancer, suggesting sensitivity and toxic side effects of chemotherapeutic drugs. Hereditary risk assessment- Covering HRR pathway genes, suggesting pathogenic and suspected pathogenic variants, guiding PARP inhibitor therapy, and suggesting genetic risk based on family tumor history and other information. Applicable Population of Individualized Medication Guidance for Prostate Cancer Prognosis,
Prostate Cancer Prevention
,Prostate Cancer Therapy
Prostate cancer patients who have relapsed, drug-resistant problem.
Prostate cancer patients who have been diagnosed with prostate cancer, and need liquid biopsy for targeted therapy and immunotherapy.
Late-stage newly diagnosed prostate cancer patients who need targeted therapy and immunotherapy.
If you want to know more details of chemotherapy for prostate cancer, please visit our website. As an ivd in vitro diagnostic
company, we can offer sorts of ivd in vitro diagnostic
equipment for sale, if you are interested, please leave us a message.

| Registration Date | 2022/12/09(Year/Month/Date) |
|---|---|
| Buyer / Seller in EC21 | Seller |
| Business Type | Manufacturer |
| Year established | 2012 |
| Employees total | 51 - 100 |
| Annual revenue | USD 1,000,001 - 2,000,000 |
| Company | CapitalBio Technology Co, Ltd. |
|---|---|
| Address | Building C, Block 88 Kechuang 6th Street, Yizhuang Biomedical Park, BeijingBeijingBeijingChina |
| Phone | 86 - 010 - 69002900 |
| Homepage | www.capitalbiotechnology.com/ |
| Contact | capitalbio |